TACHIPIRINA

TACHIPIRINA OROSOL "500 MG GRANULES STRAWBERRY AND VANILLA FLAVOUR" 12 SACHETS IN AL"

TACHIPIRINA OROSOL "500 MG GRANULES STRAWBERRY AND VANILLA FLAVOUR" 12 SACHETS IN AL"

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Name
TACHIPIRINA OROSOLUBILE 500 mg strawberry-vanilla flavored granules
Paracetamol


What is it and what is it for?
Paracetamol belongs to the pharmacotherapeutic class of analgesics (painkillers) that also act simultaneously as antipyretics (drugs that lower fever) with weak anti-inflammatory effects.

TACHIPIRINA OROSOLUBILE is used to lower fever and provide relief from mild to moderate pain.


What you need to know before taking the medicine
Do not take TACHIPIRINA OROSOLUBILE
- if you are allergic to paracetamol or any of the other ingredients of this medicine (listed in section 6);
- if you suffer from severe kidney failure;
- if you abuse alcohol.


Warnings and precautions
Talk to your doctor or pharmacist before taking TACHIPIRINA OROSOLUBILE.

Take special care with TACHIPIRINA OROSOLUBILE: - If you suffer from severe renal insufficiency;
- The risks of overdose are greater in patients with non-cirrhotic alcoholic liver disease;
- Never exceed the recommended dose:
- if you suffer from chronic alcoholism;
- if you have glucose-6-phosphate dehydrogenase deficiency;
- if you suffer from haemolytic anaemia;
- if you suffer from liver failure or Gilbert's syndrome (familial non-haemolytic jaundice) or acute hepatitis, or are taking concomitant drugs that alter liver function.

During treatment with TACHIPIRINA OROSOLUBILE, inform your doctor immediately if:
If you have serious illnesses, including severe kidney failure or sepsis (when bacteria and their toxins circulate in the blood, causing organ damage), malnutrition, chronic alcoholism, or if you are also taking flucloxacillin (an antibiotic). A serious condition called metabolic acidosis (an abnormality of the blood and fluids) has been reported in patients with these conditions when paracetamol is used at regular doses over a prolonged period or when paracetamol is taken in combination with flucloxacillin. Symptoms of metabolic acidosis may include severe breathing difficulties with rapid, deep breathing, drowsiness, nausea, and vomiting.

Prolonged or frequent use is not recommended. Patients should be advised not to take other products containing paracetamol simultaneously. Taking multiple daily doses in a single administration can seriously damage the liver. If this occurs, the patient will not lose consciousness, but a doctor should be consulted immediately. Prolonged use without medical supervision may be harmful. In children treated with 60 mg/kg of paracetamol per day, combining it with another antipyretic is not justified unless the drug is ineffective.

Caution should be exercised when administering paracetamol to patients with renal insufficiency (creatinine clearance ≥30 ml/min. (see paragraph 3 "HOW TO TAKE TACHIPIRINA OROSOLUBILE")), mild to moderate hepatocellular insufficiency (including Gilbert's syndrome), severe hepatic insufficiency (Child-Pugh >9), acute hepatitis, concomitant treatment with drugs that alter liver function, glucose-6-phosphate dehydrogenase deficiency, haemolytic anaemia.

The risks of overdose are greater in patients with non-cirrhotic alcoholic liver disease.
Caution is advised in cases of chronic alcoholism. In this case, the daily dose should not exceed 2 grams.

In case of high fever or signs of secondary infection or persistence of symptoms beyond 3 days, a reassessment of treatment should be carried out.

Paracetamol should be used with caution in cases of dehydration and chronic malnutrition. The total dose of paracetamol should not exceed 3 g per day for adults and children weighing 50 kg or more.
If your symptoms worsen or do not improve after 3 days or if you develop a high fever, you should contact your doctor.

Do not use paracetamol unless prescribed by your doctor if you have alcohol dependence or liver damage. Do not use paracetamol with alcohol. Paracetamol does not enhance the effects of alcohol.

If you are taking other painkillers containing paracetamol at the same time, do not use TACHIPIRINA OROSOLUBILE without first consulting your doctor or pharmacist.

Never take more TACHIPIRINA OROSOLUBILE than recommended. A higher dose does not increase the analgesic effect, but may instead cause serious liver damage. Symptoms of liver damage appear after a few days. For this reason, it is very important that you contact your doctor as soon as possible if you have taken more TACHIPIRINA OROSOLUBILE than recommended in this leaflet.

In case of prolonged incorrect use of high-dose painkillers, headache episodes may occur which should not be treated with higher doses of the medicine.

In general, the habitual use of painkillers, especially the combination of several analgesic drugs, can cause permanent kidney damage with the risk of kidney failure (analgesic nephropathy).

Abruptly stopping painkillers after prolonged misuse at high doses can cause headache, fatigue, muscle pain, nervousness, and autonomic symptoms. These withdrawal symptoms resolve within a few days. Until then, avoid taking other painkillers and do not restart them without consulting your doctor.

You should not take TACHIPIRINA OROSOLUBILE for prolonged periods or in high doses without consulting your doctor or pharmacist.


Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

The frequency of "rare" means that it affects 1 to 10 users in 10,000.
The frequency of "very rare" means that less than 1 in 10,000 people are affected.
Frequency not known means an effect that cannot be estimated from the available data.

The following rare side effects may occur:
• non-hemolytic anemia and bone marrow depression;
• anemia;
• thrombocytopenia;
• edema;
• diseases of the exocrine pancreas: acute and chronic pancreatitis;
• gastrointestinal bleeding, abdominal pain, diarrhea, nausea, vomiting;
• liver failure, liver necrosis, jaundice;
• allergic conditions, anaphylactic reactions, drug or food allergies;
• urticaria, pruritus, rash, sweating, purpura, angioedema;
• nephropathies and tubular disorders.

Frequency not known: serious condition that can make the blood more acidic (called metabolic acidosis), in patients with a serious illness who use paracetamol (see section 2).

Very rare cases of serious skin reactions have been reported.

Reporting of side effects
If you experience any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse .
By reporting side effects you can help provide more information on the safety of this medicine.

TACHIPIRINA

TACHIPIRINA OROSOL "500 MG GRANULES STRAWBERRY AND VANILLA FLAVOUR" 12 SACHETS IN AL"

TACHIPIRINA OROSOL "500 MG GRANULES STRAWBERRY AND VANILLA FLAVOUR" 12 SACHETS IN AL"

MINSAN code: 040313049
Previous price: €8,50
Regular price €8,50
Regular price €0,00 Sale price €8,50
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.